首页> 外国专利> MULTILAMELLAR LIPID VESICLE COMPOSITIONS INCLUDING A CONJUGATED ANAPLASTIC LYMPHOMA KINASE (ALK) VARIANT AND USES THEREOF

MULTILAMELLAR LIPID VESICLE COMPOSITIONS INCLUDING A CONJUGATED ANAPLASTIC LYMPHOMA KINASE (ALK) VARIANT AND USES THEREOF

机译:多层脂质囊泡组合物,包括共轭的再生障碍性淋巴激酶(ALK)变异体及其用途

摘要

The invention provides compositions including stabilized multilamellar lipid vesicles having crosslinked lipid bilayers (referred to herein as interbilayer-crosslinked multilamellar vesicles or ICMV) and including an ALK variant, pharmaceutical compositions containing vesicles (e.g., ICMV) including an ALK variant, and methods of treatment using such compositions. The invention provides compositions including stabilized multilamellar lipid vesicles with crosslinked lipid bilayers (e.g., an interbilayer-crosslinked multilamellar vesicle or ICMV) containing an Anaplastic lymphoma kinase (ALK) variant as an antigen that is associated with solid tumor cancers.
机译:本发明提供了组合物,其包括具有交联的脂质双层的稳定化的多层脂质囊泡(在本文中称为双层间交联的多层囊泡或ICMV),并且包括ALK变体,包含囊泡的药物组合物(例如,ICMV)以及ALK变体,以及治疗方法使用这种组合物。本发明提供了包含稳定的多层脂质囊泡的组合物,该脂质囊泡具有交联的脂质双层(例如,双层间交联的多层囊泡或ICMV),其含有间变性淋巴瘤激酶(ALK)变体作为与实体瘤癌症相关的抗原。

著录项

  • 公开/公告号US2018000906A1

    专利类型

  • 公开/公告日2018-01-04

    原文格式PDF

  • 申请/专利权人 VEDANTRA PHANNACEUTICALS INC.;

    申请/专利号US201615543127

  • 发明设计人 ADRIENNE LI;JACKSON EBY;PETER C. DEMUTH;

    申请日2016-01-15

  • 分类号A61K38/45;C12N9/78;C12N9/12;C12N9/10;A61K31/4545;A61K38/50;C07K14/495;C07K14/47;A61K39/395;A61K39/39;A61K39;A61K47/69;A61K31/506;

  • 国家 US

  • 入库时间 2022-08-21 13:00:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号